CAS: 81136-42-7; 4-Chloro-6-Ethylthieno[2,3-D]Pyrimidine

该化合物是一种以其独特结构为特征的七环环化合物,包括一个含有氯原子和乙基组替代物的三环核[2,3-d],该化合物通常具有与乙基循环有关的特性,例如有机溶剂中的中溶性以及由于氯原子的存在而可能具有的再活动性,这些原子可以参与核生殖替代反应.硫基[2,3-d]框架因其生物活动而闻名,使这种对药用化学的兴趣化合物成为其化合物,特别是在药物研制过程中.其分子结构有助于其作为各种生物路径中的抑制剂或调节剂的潜力.此外,乙基组的存在可以影响化合物的脂色性和总体的相光学特性.许多乙基环化合物的具体特性,包括熔点,沸点和光谱系数据,可以从可靠的化学数据库和精确的文献中加以参考.

结构式图片

相似化合物

439692-82-7 87478-74-8 439692-52-1

欧盟法规

C&L通报

上下游产品

pyrimidine4-oxo-(3H)-6-ethylthieno2,3-dpyrimidine ethyl 2-amino-5-ethylthiophene-3-carboxylate H-thieno[2,3-d]pyrimidin-4-one6-ethyl-3H-thieno[2,3-d]pyrimidin-4-one pyrimidine4-(4-iodophenyl)amino-6-ethyl2,3-dpyrimidine 6-ethyl-N-(phenylmethyl)thieno[2,3-d]pyrimidin-4-amine

合成工艺路线路线简述

  • 75-12-7 + 4507-13-5 = 81136-42-7
    反应条件:1.1 Solvents: Formamide; 8 H,180 °C2.1 Reagents: Phosphorus Oxychloride Solvents: Toluene; 4 H,100 °C2.2 Reagents: Ammonia Solvents: Water; Cooled
    标题:Synthesis And Cytotoxic Evaluation Of Novel Benzimidazole Fused Condensed Thienopyrimdines Derivatives
    作者:Kaliraj,S.; Et Al
    参考文献:Current Bioactive Compounds 日期:2020 卷标:16(2) 页码:133-141]

    105-56-6 = 81136-42-7
    反应条件:1.1 Reagents: Morpholine,Sulfur Solvents: Ethanol; Rt2.1 8 H,210 °C3.1 Reagents: Phosphorus Oxychloride Solvents: Toluene; Cooled; 105 °C
    标题:Synthesis,Cytotoxic Activity And Molecular Docking Studies Of New Condensed Thieno[2,3-D]Pyrimidines As Antitumor Agents
    作者:Kaliraj,S.; Et Al
    参考文献:Pharmaceutical Chemistry Journal 日期:2020 卷标:54(3) 页码:258-267]

    105-56-6 = 81136-42-7
    反应条件:1.1 Reagents: Diethylamine,Sulfur Solvents: Ethanol; 12 H,Rt; 14 H,Rt2.1 24 H,160 - 170 °C3.1 Reagents: Phosphorus Oxychloride,Phosphorus Pentachloride; Rt -> 105 °C; 5 - 6 H,105 °C3.2 Reagents: Sodium Hydroxide Solvents: Dichloromethane,Water; Neutralized,Cooled
    标题:Design And Synthesis Of Novel Protein Kinase Ck2 Inhibitors On The Base Of 4-Aminothieno[2,3-D]Pyrimidines
    作者:Ostrynska,Olga V.; Et Al
    参考文献:European Journal Of Medicinal Chemistry 日期:2016 卷标:115 页码:148-160]

    18593-51-6 = 81136-42-7
    反应条件:1.1 Reagents: Thionyl Chloride Solvents: Dimethylformamide; 3 H,80 °C
    标题:Thienopyrimidine-Based P2Y12 Platelet Aggregation Inhibitors
    作者:Kortum,Steven W.; Et Al
    参考文献:Bioorganic & Medicinal Chemistry Letters 日期:2009 卷标:19(20) 页码:5919-5923]

    75-12-7 + 19156-63-9 = 81136-42-7
    反应条件:1.1 Reagents: Ammonium Formate; 12 H,135 °C2.1 Reagents: Thionyl Chloride Solvents: Dimethylformamide; 3 H,80 °C
    标题:Thienopyrimidine-Based P2Y12 Platelet Aggregation Inhibitors
    作者:Kortum,Steven W.; Et Al
    参考文献:Bioorganic & Medicinal Chemistry Letters 日期:2009 卷标:19(20) 页码:5919-5923]

    75-12-7 + 4507-13-5 = 81136-42-7
    反应条件:1.1 8 H,210 °C2.1 Reagents: Phosphorus Oxychloride Solvents: Toluene; Cooled; 105 °C
    标题:Synthesis,Cytotoxic Activity And Molecular Docking Studies Of New Condensed Thieno[2,3-D]Pyrimidines As Antitumor Agents
    作者:Kaliraj,S.; Et Al
    参考文献:Pharmaceutical Chemistry Journal 日期:2020 卷标:54(3) 页码:258-267]

    75-12-7 + 4507-13-5 = 81136-42-7
    反应条件:1.1 24 H,160 - 170 °C2.1 Reagents: Phosphorus Oxychloride,Phosphorus Pentachloride; Rt -> 105 °C; 5 - 6 H,105 °C2.2 Reagents: Sodium Hydroxide Solvents: Dichloromethane,Water; Neutralized,Cooled
    标题:Design And Synthesis Of Novel Protein Kinase Ck2 Inhibitors On The Base Of 4-Aminothieno[2,3-D]Pyrimidines
    作者:Ostrynska,Olga V.; Et Al
    参考文献:European Journal Of Medicinal Chemistry 日期:2016 卷标:115 页码:148-160]

    105-34-0 = 81136-42-7
    反应条件:1.1 Reagents: Triethylamine,Sulfur; Rt1.2 45 - 50 °C; 18 H,Rt2.1 Reagents: Ammonium Formate; 12 H,135 °C3.1 Reagents: Thionyl Chloride Solvents: Dimethylformamide; 3 H,80 °C
    标题:Thienopyrimidine-Based P2Y12 Platelet Aggregation Inhibitors
    作者:Kortum,Steven W.; Et Al
    参考文献:Bioorganic & Medicinal Chemistry Letters 日期:2009 卷标:19(20) 页码:5919-5923]

    105-56-6 = 81136-42-7
    反应条件:1.1 Reagents: Sulfur Solvents: Dimethylformamide; 6 H,50 °C1.2 Reagents: Triethylamine; 30 Min; 12 H,Rt; Overnight,0 °C2.1 Solvents: Formamide; 8 H,180 °C3.1 Reagents: Phosphorus Oxychloride Solvents: Toluene; 4 H,100 °C3.2 Reagents: Ammonia Solvents: Water; Cooled
    标题:Synthesis And Cytotoxic Evaluation Of Novel Benzimidazole Fused Condensed Thienopyrimdines Derivatives
    作者:Kaliraj,S.; Et Al
    参考文献:Current Bioactive Compounds 日期:2020 卷标:16(2) 页码:133-141
📜净司他丁置于五氯化磷,三氯氧磷体系中,化学反应 24.0H,反应生成 4-氯-6-乙基噻吩并[2,3-D]嘧啶
参考文献:基于4-氨基噻吩并[2,3-D]嘧啶的新型蛋白激酶ck2抑制剂的设计与合成
标题:基于4-氨基噻吩并[2,3-D]嘧啶的新型蛋白激酶ck2抑制剂的设计与合成
摘要:我们先前研究工作的扩展已导致在4-氨基噻吩并[2,3-D]嘧啶衍生物中鉴定出许多新的与atp竞争的ck2抑制剂.在研究过程中获得的活性最高的化合物是3-(5-对甲苯基-噻吩并[2,3-D]嘧啶-4-基氨基)苯甲酸5E(nhtp23,Ic 50 = 0.01μm),3-(5-苯基-噻吩并[2,3-D]嘧啶-4-基氨基)-苯甲酸,5G(nhtp25,Ic 50 = 0.065μm)和3-(6-甲基-5-苯基-噻吩并[2,3-D]嘧啶-4-基氨基)-苯甲酸,5N(nhtp33,Ic 50 = 0.008μm).研究了测试的4-氨基噻吩并[2,3-D]嘧啶衍生物的结构-活性关系,并提出了它们与ck2 Atp受体位点的结合方式.讨论了分子内氢键对化合物结构的负面影响.
DOI:10.1016/j.Ejmech.2016.03.004

海关参考信息

供应商参考报价(招募中)

品牌试剂参考报价(招募中)

📌 第三方产品分析报告

✅ COA系统入驻 | 共享模式

合成参考文献


参考文献:10.1038/nchembio.773
摘要:Grembecka J, He S, Shi A, Purohit T, Muntean AG, Sorenson RJ, Showalter HD, Murai MJ, Belcher AM, Hartley T, Hess JL, Cierpicki T. Menin-MLL inhibitors reverse oncogenic activity of MLL fusion proteins in leukemia. Nature Chemical Biology. 2012 Jan 29;8(3):277–84. doi: 10.1038/nchembio.773.
📝 需求与反馈
尽可能描述清楚需求与问题信息
×

通知